(Q44198865)

30 November 2017

title

Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy (English)

1 reference

30 November 2017

1 reference

1 reference

de Jonge ME

1

1 reference

30 November 2017

Mathôt RA

2

1 reference

30 November 2017

Dalesio O

3

1 reference

30 November 2017

Huitema AD

4

1 reference

30 November 2017

Rodenhuis S

5

1 reference

30 November 2017

Beijnen JH

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Bone Marrow Transplantation

30 November 2017

published in

1 reference

30 November 2017

volume

30

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

593-597

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703695

30 November 2017

exact match

0 references

cites work

On the receiving end--patient perception of the side-effects of cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Cutaneous reactions to chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantion incorporating carboplatin, cyclophosphamide and thiotepa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

The psychosocial consequences of androgenetic alopecia: a review of the research literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Protection against Chemotherapy-Induced Alopecia by Cyclosporin A in the Newborn Rat Animal Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Protection against cyclophosphamide-induced alopecia and inhibition of mammary tumor growth by topical 1,25-dihydroxyvitamin D3 in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

A New Strategy for Modulating Chemotherapy-Induced Alopecia, Using PTH/PTHrP Receptor Agonist and Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Pharmacokinetically guided administration of chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Chemistry, pharmacology and pharmacokinetics of N,N',N" -triethylenethiophosphoramide (ThioTEPA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

The status of high-dose chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

Chemotherapy-induced alopecia: new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

7 January 2021

Permanent alopecia following chemotherapy and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

7 January 2021

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

7 January 2021

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

7 January 2021

A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

7 January 2021

Prevention of chemotherapy-induced alopecia using an effective scalp cooling system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

7 January 2021

Clinical pharmacokinetics of cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703695

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703695

1 reference

30 November 2017

1 reference